
OpenEvidence
$521.23
Source:$50.39 (10.70%)past six months
OpenEvidence Valuation
Follow estimated valuations, share price trends, and company updates for OpenEvidence.
About OpenEvidence
OpenEvidence delivers an AI-driven platform that helps healthcare professionals effortlessly explore and understand medical research. It synthesizes peer-reviewed clinical studies and multimedia into digestible insights that support informed decision making at the point of care. The platform seamlessly integrates evidence-based content into clinicians’ workflows to enhance patient outcomes.
| Co-Founder | Zachary Ziegler |
| CEO | Daniel Nadler |
| CTO | Zachary Ziegler |
| Headquarters | Cambridge, MA |
| Founded | 2019 |
| Sector | Healthcare & Life Sciences |
OpenEvidence Funding History
| Financing Round | Date | Amount |
|---|---|---|
| Series D | Jan 21, 2026 | $225M |
| Series C-2 | Oct 20, 2025 | $75M |
| Series C-2 | Oct 20, 2025 | $125M |
| Series B-1 | Jul 15, 2025 | $125M |
| Series B-1 | Jul 15, 2025 | $30M |
| Series A | Feb 19, 2025 | $75M |
OpenEvidence lead investors
- Blackstone
- BOND
- Coatue
- Craft Ventures
- DST Global
- Google Ventures
- Greycroft
- Kleiner Perkins Caufield & Byers
- Sequoia
- Thrive Capital
FAQ
Frequently asked questions
OpenEvidence's estimated secondary market share price is $521.23 as of July 2026.
OpenEvidence's last official round, Series D, was for $225M.
OpenEvidence's last known funding was on Jan 21, 2026 for $225M.
OpenEvidence's major investors are Blackstone, BOND, Coatue, Craft Ventures, DST Global, Google Ventures, Greycroft, Kleiner Perkins Caufield & Byers, Sequoia, Thrive Capital.
As of August 31, 2026, OpenEvidence is not yet publicly traded.
Private companies
OpenAIOPEA+4.63%
StripeSTRI+12.57%
DatabricksDABR+32.11%
AnthropicANTH+169.40%
PerplexityPERP-5.44%
NeuralinkNEUL+152.87%
AndurilADUI+30.33%
OpenEvidence Valuation
Follow estimated valuations, share price trends, and company updates for OpenEvidence.
Private companies
OpenAIOPEA+4.63%
StripeSTRI+12.57%
DatabricksDABR+32.11%
AnthropicANTH+169.40%
PerplexityPERP-5.44%
NeuralinkNEUL+152.87%
AndurilADUI+30.33%